Highlights Sandoz Group AG

Equities

Market Closed - Swiss Exchange Other stock markets 09:00:12 24/05/2024 pm IST			5-day change	1st Jan Change
32.02 ^CHF	-0.93%		+0.09%	+18.33%

22/05	Sandoz: Marketing authorization for Wyost and Jubbonti in the EU	CF
22/05	Sandoz Group Receives EU Approval for Cancer, Osteoporosis Biosimilars	MT

AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	09/05	MT
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	09/05	MT
AstraZeneca, Merck Sue Over Alleged Cancer Drug Patents Infringement	08/05	MT
Swiss Market Index Closes Higher; Sandoz Gains	08/05	MT
SANDOZ : Sandoz’s improvements are worth betting on	08/05
SANDOZ : Q1 miss not a worry; expect another boost for the share price	07/05
Sandoz: 5% sales growth in Q1	07/05	CF
Sandoz Group Logs Growth in Q1 Net Sales, Affirms FY24 Outlook	07/05	MT
Sandoz Group Ag Reiterates Earnings Guidance for the Full Year 2024	07/05	CI
Global markets live: Adidas, Mercedes, McDonalds, Eli Lilly, PayPal, MicroStrategy, Tesla...	30/04
Sandoz Group AG Approves Dividend, Payable on May 7, 2024	30/04	CI
Sandoz Reaches Agreement With Amgen Resolving All Patent Litigation	30/04	DJ
Sandoz Group Settles Patent Disputes with Amgen	30/04	MT
Sandoz reaches agreement with Amgen over patent dispute	30/04	RE
Cigna to offer Humira rivals with $0 copay at specialty pharmacy	26/04	RE
Sandoz Confirms European Commission Approval of Pyzchiva® (ustekinumab), Further Strengthening Immunology Offering	22/04	CI
Bausch wins US appeal to block Alvogen generic of diarrhea drug	11/04	RE
Sandoz: new production site in Kundl	21/03	CF
Sandoz Launches New Antibiotic Production Plant in Kundl, Austria	21/03	MT
Sandoz Group Opens New Antibiotic Production Facility in Kundl, Austria	21/03	MT

No results for this search

SANDOZ : Sandoz’s improvements are worth betting on

May 08, 2024 at 05:38 pm IST